SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,003.82 -777.94
( -1.04%)

Global Indices

Nasdaq

52,442.46 -151.83
(-0.29%)

Dow Jones

7,640.91 -37.07
(-0.48%)

Hang Seng

63,634.18 141.19
(0.22%)

Nikkei 225

10,654.59 -42.98
(-0.40%)

Forex

USD-INR

95.47 0.03
(0.03%)

EUR-INR

110.72 -0.23
(-0.20%)

GBP-INR

129.12 -0.04
(-0.03%)

JPY-INR

0.62 0.00
(0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524742

INE475E01026

269.7614245

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CAPLIPOINT

46.56

19541.09

EPS(TTM)

Face Value()

Div & Yield %

55.22

0.31

Back

Kreon Finnancial Services standalone net profit rises 16.98% in the June 2026 quarter

Jul 29,2026

Net profit of Kreon Finnancial Services rose 16.98% to Rs 4.41 crore in the quarter ended June 2026 as against Rs 3.77 crore during the previous quarter ended June 2025. Sales rose 44.20% to Rs 13.93 crore in the quarter ended June 2026 as against Rs 9.66 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	13.93	9.66	44
OPM %	38.33	42.96	-
PBDT	5.66	5.03	13
PBT	5.40	4.85	11
NP	4.41	3.77	17

74,003.82 -777.94 ( -1.04%)

52,442.46 -151.83 (-0.29%)

7,640.91 -37.07 (-0.48%)

63,634.18 141.19 (0.22%)

10,654.59 -42.98 (-0.40%)

95.47 0.03 (0.03%)

110.72 -0.23 (-0.20%)

129.12 -0.04 (-0.03%)

0.62 0.00 (0.29%)